NeuroSense Announces Business Updates for the First Half of 2026
2026-09-26 04:33:19
According to CoinMeta, as reported by PR Newswire, NeuroSense Therapeutics Ltd ( NASDAQ : NRSN ) provided an update on its business for the first half of 2026 today, focusing on developing disease-modifying treatment options for neurodegenerative diseases.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.